RT Journal Article
SR Electronic
T1 No association between circulating levels of testosterone and sex hormone-binding globulin and risk of COVID-19 mortality in UK biobank
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.11.20191783
DO 10.1101/2020.09.11.20191783
A1 Fan, Xikang
A1 Yang, Jing
A1 Wang, Jiayu
A1 Yin, Cheng
A1 Zhu, Meng
A1 Ma, Hongxia
A1 Jin, Guangfu
A1 Hu, Zhibin
A1 Shen, Hongbing
A1 Hang, Dong
YR 2020
UL http://medrxiv.org/content/early/2020/09/11/2020.09.11.20191783.abstract
AB Background Sex-disaggregated data suggest that men with coronavirus disease 2019 (COVID-19) are more likely to die than women. Whether circulating testosterone or sex hormone-binding globulin (SHBG) contributes to such sex differences remains unknown.Objective To evaluate the associations of circulating total testosterone (TT), free testosterone (FT), and SHBG with COVID-19 mortality.Design Prospective analysis.Setting UK Biobank.Participants We included 1306 COVID-19 patients (678 men and 628 women) who had serum TT and SHBG measurements and were free of cardiovascular disease or cancer at baseline (2006-2010).Main outcome measures The death cases of COVID-19 were identified from National Health Service death records updated at 31 July 2020. Unconditional logistic regression was performed to estimate the odds ratio (OR) and 95% confidence intervals (CI) for mortality.Results We documented 315 deaths of COVID-19 (194 men and 121 women). After adjusting for potential confounders, we did not find any statistically significant associations for TT (OR per 1-SD increase = 1.03, 95% CI: 0.85-1.25), FT (OR per 1-SD increase = 0.95, 95% CI: 0.77-1.17), or SHBG (OR per 1-SD increase = 1.09, 95% CI: 0.87-1.37) with COVID-19 mortality in men. Similar null results were observed in women (TT: OR per 1-SD increase = 1.10, 95% CI: 0.85-1.42; FT: OR per 1-SD increase = 1.10, 95% CI: 0.82-1.46; SHBG: OR per 1-SD increase = 1.16, 95% CI: 0.89-1.53).Conclusions Our findings do not support a significant role of circulating testosterone or SHBG in COVID-19 prognosis.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialUK Biobank received ethical approval from the NHS National Research Ethics Service North West (11/NW/0382; 16/NW/0274).Clinical Protocols https://www.ukbiobank.ac.uk/wp-content/uploads/2011/11/UK-Biobank-Protocol.pdf Funding StatementThis study was funded by National Natural Science Foundation of China (81820108028, 81521004, and 81973127), National Key R&D Program of China (2016YFC1000200 and 2017YFC0908300), and Science Foundation for Excellent Young Scholars of Jiangsu (BK20190083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UK Biobank received ethical approval from the NHS National Research Ethics Service North West (11/NW/0382; 16/NW/0274). All participants provided written informed consent before enrolment in the study, which was conducted in accordance with the Declaration of Helsinki. The study protocol is available online (https://www.ukbiobank.ac.uk/wp-content/uploads/2011/11/UK-Biobank-Protocol.pdf).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from UK Biobank (https://www.ukbiobank.ac.uk/), but restrictions apply to their availability. These data were used under licence for the current study and so are not publicly available. The data are available from the authors upon reasonable request and with permission of UK Biobank. http://biobank.ndph.ox.ac.uk/showcase/